Stroke
November 2014
Before the start of the study, 2 patients with BAVMs at one of the centers were known to have 1 FDR with a BAVM. 6 Each patient was approached by postal questionnaire to ascertain information about the occurrence in FDRs (ie, parents, sibs, and children) of BAVMs (question 1), intracranial vascular malformations (question 2), hemorrhagic strokes (question 3), seizures (question 4), neurological deficits (question 5), sudden deaths (question 6), and performed neuroimaging (question 7). We resent the questionnaire to nonresponders after 1 month. If an index patient had died, we attempted to approach a next-of-kin to complete the questionnaire on behalf of the deceased index patient after contacting the patient's general practitioner. We applied several strategies to improve response, such as provision of a stamped return envelope, personation of letters, signing letters by hand, using a short questionnaire, and using reminders. 8 Each FDR with a possible BAVM was approached by a letter about the study sent to this relative by the index patient to ask for participation in the study. Only after obtaining the relative's approval and informed consent, we received additional information from the FDR by telephone and by retrieval of medical information when indicated. For deceased relatives, a next-of-kin was interviewed about the cause of death. In case of brain-related death, medical records were retrieved to clarify the cause of death with approval and informed consent of a legal representative.
The study was approved by the institutional ethical committee of the University Medical Center Utrecht.
Data Collection
For all FDRs, we obtained information on whether they had a diagnosis of BAVM or an alternative diagnosis in case of vascular malformations, hemorrhagic stroke, seizure(s), neurological deficit(s), sudden death, or previous neuroimaging if the index patient had given a positive answer to ≥1 of the questions.
In all index patients and all FDRs with a proven BAVM, we reviewed medical files for age at presentation, sex, mode of presentation, location of the BAVM (lobar, deep, and infratentorial), and diagnostic modality (digital subtraction angiography, magnetic resonance imaging, computed tomography angiography, or pathological examination).
Statistical Analysis
We estimated the risk of having a BAVM among FDRs by calculating a prevalence ratio using the observed BAVM prevalence among the FDRs versus the prevalence in a Scottish population-based study. 7 Because population-based cohorts of BAVMs are scarce, 7, 9 we regarded prevalence data from a nearby European country most appropriate as reference. 7 We compared age, sex, and proportion of patients with a ruptured BAVM between the Dutch index patients and the Scottish cohort using parametric statistics when data obeyed a normal distribution and nonparametric statistics when they did not. In the Scottish cohort, the minimum crude BAVM prevalence was 93 per 628 788 adults and the maximum adjusted prevalence after capture-recapture analysis 113 per 628 788 adults. 7 We calculated the prevalence ratio with the adjusted prevalence as sensitivity analysis. Because the Scottish population-based cohort reported on residents aged ≥16, we also repeated the analysis excluding FDRs who were aged <16 years at the time of the data collection. Finally, we repeated the analysis using the prevalence of symptomatic BAVMs (73 per 628 788 adults). 7, 10 On the basis of our experience with familial intracranial aneurysms, 11 combined with the fact that 2 patients with BAVM at one of the participating centers were already known to have 1 FDR with a BAVM, 6 we prespecified a prevalence ratio of ≥9 with a lower limit of the 95% CI of 3 as indicative of true familial aggregation based on a shared familial risk factor.
Results
Of a total of 770 patients, 682 (89%) were approached for this study. Contact information could not be traced for 71 (9.2%), an additional 7 (0.91%) patients had moved abroad, and for 10 (1.3%) patients who had died the general practitioner was not able to refer to family members. Informed consent was given by 460 of the 682 (67%) contacted patients. There were no important differences in demographics, mode of presentation, BAVM location, or in the way the diagnosis of a BAVM was confirmed between responders and nonresponders ( Table  I in the online-only Data Supplement). The participating index patients were younger at the time of presentation with a BAVM than patients in the Scottish reference population (38 versus 45 years; mean difference, 7.0; 95% CI, 3.7-10), 10 but both groups did not differ with respect to sex and presentation with a ruptured BAVM (Table II in the online-only Data Supplement).
Baseline characteristics of the participating index patients are summarized in Table 1 . Eighty-eight (19%) of the 460 index patients were aged <16 years when they presented with their BAVMs. The 460 patients had a total of 2992 FDRs (median, 6; interquartile range, 4).
The results of the postal questionnaire are summarized in the Figure and Table 2 . The questionnaires indicated the absence of BAVMs in 2919 FDRs. Two index patients reported a BAVM in a FDR; in both, the diagnosis was confirmed by the medical files (Table 3 ). BAVMs could not be excluded in 71 FDRs because of insufficient information (Table 2) . Details with respect to these 71 FDRs are provided in the online-only Data Supplement.
Thus, based on the responses to the questionnaire, 2 of 2992 FDRs of the index patients with BAVMs had a confirmed BAVM. During the analyses, a FDR of a third index patient (Table 3) presented with a ruptured BAVM. Including this third family, the prevalence ratio of BAVMs in FDRs when compared with the general Scottish population was 6.8 (95% CI, 2.2-21) if the minimum crude prevalence (93 per 628 788) was used, and 5.6 (95% CI, 1.8-18) if the adjusted prevalence (113 per 628 788) was used. 7 If analyses were restricted to FDRs aged ≥16 years, the prevalence ratio was 6.9 (95% CI, 2.2-22). Exclusion of the 71 FDRs in whom BAVMs could not be excluded because of insufficient information (online-only Data Supplement) yielded a prevalence ratio of 6.9 (95% CI, 2.2-22). Finally, when we compared the prevalence in FDRs with the prevalence of symptomatic BAVMs in the Scottish study, 7,10 the prevalence ratio was 8.6 (95% CI, 2.7-27).
Discussion
The risk of having a BAVM was increased in FDRs of patients with BAVMs, but the prevalence ratio of 6.8 (95% CI, 2.2-22) did not meet our prespecified criterion, indicating true familial aggregation. In combination with the low absolute risk of a BAVM in FDRs, our results do not support screening of FDRs for BAVMs. We are not aware of other studies that have systematically investigated the familial occurrence of BAVMs among FDRs in a large cohort of patients with a BAVM. Several cases of familial BAVMs have been published. 5, 6, 12, 13 In our review of the literature on familial occurrence of BAVMs, the clinical characteristics of patients with familial BAVMs were similar to those of patients with a sporadic BAVM, except for those patients with familial BAVMs were diagnosed at younger age. 6 In families with BAVMs in ≥2 successive generations, children were younger at the time of diagnosis than their parents. This difference could not be explained by screening for familial BAVM. 6 A higher than expected prevalence of BAVMs in FDRs of patients with a BAVM may suggest a genetic basis for the development of BAVMs. Several relatively small studies have found associations between single nucleotide polymorphisms and sporadic BAVMs. 14, 15 In a recent review and meta-analysis, the activin receptor-like kinase 1 intervening sequence 3 −35A>G polymorphism was associated with susceptibility to develop BAVMs and the single nucleotide polymorphisms interleukin 6 −174G>C and tumor necrosis factor α −238G>A were associated with BAVM hemorrhage.
14 Genome-wide association studies in a large cohort of patients have not yet been published.
Given the low prevalence of BAVMs in FDRs of patients with BAVMs and the fact that benefits of interventional treatment of asymptomatic BAVMs are at best uncertain on the short term 16 and on the long term, [17] [18] [19] we do not recommend screening of asymptomatic FDRs of patients with a BAVM. Although it is remarkable that 2 of the 3 index patients with a FDR with a BAVM were teenagers at the time of presentation, the number of patients with BAVM in our cohort who presented <16 years was too small to draw conclusions, and therefore screening for this age group cannot be recommended.
In the future, improved prediction of hemorrhage in patients with BAVMs may aid in the decision whether unruptured or even asymptomatic BAVMs should be treated. The presence of silent intralesional microhemorrhages has been suggested as a marker of future hemorrhage, but their predictive value needs confirmation in prospective studies. 20, 21 In current daily practice, special attention should be given to the family history and the possibility of hereditary hemorrhagic telangiectasia in patients with a BAVM. 3, 22 In case of familial occurrence of BAVMs, multiplicity of BAVMs, or suspected underlying hereditary hemorrhagic telangiectasia, patients should be referred to a clinical geneticist.
A strength of our study is that we made an effort to avoid potential recall bias by retrieving medical files of the FDRs to obtain either BAVM diagnosis or alternative diagnoses. The response rate (67%) to our postal questionnaire was reasonable, but we cannot exclude that FDRs with BAVMs have been missed among the nonresponders. Another strength is the noninvasive nature of this study, using only existing medical information on the FDRs. At the same time this is a limitation, because BAVMs are asymptomatic in 6% to 20% of the cases, 10, 23 and therefore it is likely that our results are an underestimation of the familial occurrence of BAVMs. Some relatives may have a BAVM that has not yet been detected or may never be detected. The FDR that presented with a ruptured BAVM during the analysis supports this potential underestimation of the true familial prevalence of BAVMs. BAVMs in FDRs may also have been missed because of the unavailability of medical records or because of a less thorough approach to detect underlying causes of intracranial hemorrhage in the 1970s and 1980s in comparison with the period of 1999 to 2003 when the adults with BAVMs in the prospective Scottish population-based cohort were included. Although it is possible that the 11 FDRs who suddenly died of suspected of hemorrhagic stroke at a median age of 64 years had a BAVM-related stroke, it is more likely that their stroke was because of aneurysmal hemorrhage or spontaneous hemorrhage because of the higher incidence of aneurysms than BAVMs, the relatively high ages at the time of stroke, and the higher case fatality of aneurysmal-related hemorrhage and spontaneous intracranial hemorrhage. Finally, affected relatives may have been underascertained because they were unknown to our index cases or because of misattributed paternity. General limitations of family history studies may also apply to ours, 24 such as recall and response bias or chance effects. Furthermore, by approaching patients from 4 tertiary referrals centers, a referral bias can be induced because families with a positive family history may be more likely to be referred. It is important to realize that the 2 of the 3 families included in the analyses were already known to the investigators. 6 The third case of a BAVM in a FDR presented after we had completed our first analysis.
Conclusions
On the basis of the results of our study, we conclude that patients with BAVMs and their FDRs can be reassured that although the risk of having a BAVM may be higher than in the general population, the absolute risk is low. Therefore, screening of FDRs of patients with a BAVM is not recommended. 
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In 24 (5.2%) index patients we were not able to complete the family history with definite diagnoses for 39 (20%) of their 195 FDRs because index patients or their FDRs declined (further) participation in the study or did not respond to our letters. According to the survey results, vascular malformations (other than BAVM) were thought to be present in five FDRs, hemorrhagic stroke in 10, focal neurological deficits in 5, seizures in 8, and imaging was thought to be performed in 11 FDRs.
Medical files could not be retrieved in 32 (12%) of the 264 FDRs from 28 (6.1%) index patients. In 23 of these 32 FDRs, these events occurred in or before 1986. Ten FDRs had died suddenly with an uncertain cause of death: two FDRs one day after they were born, one as a baby, one at the age of five, three around the age of 18 years, and another two at the age of 41 and 68. One relative was thought to have been diagnosed with a vascular malformation around 1980. Another 11 FDRs suddenly died of suspected of hemorrhagic stroke (median age of death 64 years, range 40-86 years), and one of these relatives was thought to have been diagnosed with a vascular malformation at the age of 84 years. Hemorrhagic stroke could not be confirmed in another four FDRs due to absence of medical files. Four FDRs were supposedly diagnosed with seizures and one with a focal neurological deficit for which he received a scan. In 52 patients the possibility of familial occurrence of BAVMs could not be ruled out in 71 FDRs due to refusal to cooperate or missing medical files. Importantly, these 52 patients did not report familial occurrence of BAVMs (i.e. Question 1) among FDRs but reported other vascular malformations (i.e. Question 2) in seven relatives. 
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